Bonesupport Holding AB BONEX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 232.00
- Day Range
- SEK 219.40–233.40
- 52-Week Range
- SEK 94.65–255.00
- Bid/Ask
- SEK 225.40 / SEK 226.00
- Market Cap
- SEK 14.91 Bil
- Volume/Avg
- 179,556 / 191,451
Key Statistics
- Price/Earnings (Normalized)
- 55.20
- Price/Sales
- 23.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 121
- Website
- https://www.bonesupport.com
Comparables
Valuation
|
Metric
|
BONEX
|
ELOS B
|
BACTI B
|
|---|---|---|---|
Price/Earnings (Normalized) | 55.20 | — | — |
Price/Book Value | 27.19 | 2.80 | 7.02 |
Price/Sales | 23.92 | — | 11.96 |
Price/Cash Flow | 169.28 | — | — |
Price/Earnings
BONEX
ELOS B
BACTI B
Financial Strength
|
Metric
|
BONEX
|
ELOS B
|
BACTI B
|
|---|---|---|---|
Quick Ratio | 2.18 | 0.40 | 1.64 |
Current Ratio | 3.14 | 1.99 | 1.94 |
Interest Coverage | — | 6.73 | −11.31 |
Quick Ratio
BONEX
ELOS B
BACTI B
Profitability
|
Metric
|
BONEX
|
ELOS B
|
BACTI B
|
|---|---|---|---|
Return on Assets (Normalized) | 52.91% | 7.39% | −17.77% |
Return on Equity (Normalized) | 67.26% | 13.33% | −32.17% |
Return on Invested Capital (Normalized) | 64.73% | 12.76% | −19.44% |
Return on Assets
BONEX
ELOS B
BACTI B
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Stcvjxfvfj | Bfy | $133.1 Bil | |
BDX
| Becton Dickinson & Co | Lnxcbczk | Lcxyfc | $66.9 Bil | |
ALC
| Alcon Inc | Nxsjrxgpg | Dzzgkzz | $38.9 Bil | |
RMD
| ResMed Inc | Cmsnkfmsxt | Lspvrz | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Cxzhcbykqw | Bykc | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Jdvgztps | Yps | $26.4 Bil | |
BAX
| Baxter International Inc | Wgcvspjr | Fryhwlj | $20.4 Bil | |
HOLX
| Hologic Inc | Rctlgbtx | Mgqqn | $17.8 Bil | |
COO
| The Cooper Companies Inc | Fmfbrjfz | Wjphwh | $17.7 Bil | |
TFX
| Teleflex Inc | Hzbrk | Svzd | $9.7 Bil |